News & Perspective

Oct 15, 2012

Oct 15, 2012

A game-changing approach to investigating flu vaccines

Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

Jul 06, 2012

Jul 06, 2012

FLU NEWS SCAN: Resistant H1N1, H5N1 in Indonesia

Antiviral-resistant H1N1 virus in Australia didn't spread farAn oseltamivir-resistant 2009 H1N1 virus that spread in one Australian community in 2011 apparently did not escape to a nearby large city, according to a report published in Eurosurveillance yesterday. Researchers previously reported the community spread of a resistant 2009 H1N1 virus in the Newcastle, Australia, area from June through August of 2011, the report notes.

Jun 27, 2012

Jun 27, 2012

CDC estimate of global H1N1 pandemic deaths: 284,000

(CIDRAP News) – Working with admittedly sparse data, a research team led by the US Centers for Disease Control and Prevention (CDC) has estimated the global death toll from the 2009 H1N1 influenza pandemic at more than 284,000, about 15 times the number of laboratory-confirmed cases.

Jun 26, 2012

Jun 26, 2012

HHS lists H1N1's lessons for honing pandemic readiness

(CIDRAP News) – During the 2009 influenza pandemic, clinicians were frustrated by the lack of useful diagnostic tests, the government had no national system for monitoring stress on healthcare facilities, and there was some duplication in federal media campaigns.

Apr 23, 2012

Apr 23, 2012

Study: Mexico's H1N1 mortality rose as antiviral use dropped

(CIDRAP News) – A large-scale study suggests that antiviral treatment saved many lives during Mexico's 2009 H1N1 influenza pandemic but also points to an irony: that the use of antivirals dropped sharply in the fall wave of cases.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»